Browsing by Author "Mwelase, Noluthando"

Fale com a Fiocruz

Fundação Oswaldo Cruz

Now showing items 1-14 of 14

As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial

Hosseinipour, Mina C. et al. | Date Issued: 2018
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings

Tenforde, Mark W. et al. | Date Issued: 2015
Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation

Shivakoti, Rupak et al. | Date Issued: 2015
Dolutegravir-based antiretroviral therapy for patients co-infected with tuberculosis and HIV: a multicenter, noncomparative, open-label, randomized trial

Dooley, Kelly E. et al. | Date Issued: 2019
Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy

Nyirenda, Mulinda et al. | Date Issued: 2020
Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults

Mave, Vidya et al. | Date Issued: 2016
Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study

Shivakoti, Rupak et al. | Date Issued: 2018
One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis

Swindells, Susan et al. | Date Issued: 2019
Persistently elevated C-reactive protein level in the first year of antiretroviral therapy, despite virologic suppression, Is associated with HIV disease progression in resource-constrained settings

Shivakoti, Rupak et al. | Date Issued: 2016
Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy

Shivakoti, Rupak et al. | Date Issued: 2014
Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings

Epeldegui, Marta et al. | Date Issued: 2023
Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults

Shivakoti, Rupak et al. | Date Issued: 2016
Sex-related differences in inflammatory and immune activation markers before and after combined antiretroviral therapy initiation

Mathad, Jyoti S et al. | Date Issued: 2016
Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial

Krown, Susan E. et al. | Date Issued: 2020